Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Lancet Haematology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2352-3026(17)30026-1PMID 28259520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score–matched study

  2016cited by this paper
• An Algorithmic Approach to the Diagnosis and Management of the Thrombotic Microangiopathies.

  2016cited by this paper
• Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura

  2016cited by this paper
• Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).

  2016cited by this paper
• The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry

  2015cited by this paper
• Predicting the Presence of an Acute Coronary Lesion Among Patients Resuscitated From Cardiac Arrest

  2015cited by this paper
• Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative

  2015cited by this paper
• Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP)

  2013cited by this paper
• Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models

  2012cited by this paper
• Thrombotic Thrombocytopenic Purpura Associated with Mixed Connective Tissue Disease: A Case Report

  2011cited by this paper
• Survival and relapse in patients with thrombotic thrombocytopenic purpura.

  2010cited by this paper
• Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

  2010cited by this paper
• The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange

  2010cited by this paper
• Sampling Uncertainty and Confidence Intervals for the Brier Score and Brier Skill Score

  2008cited by this paper
• Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features

  2008cited by this paper
• Hyperbilirubinemia interferes with ADAMTS‐13 activity measurement by FRETS‐VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies

  2007cited by this paper
• FRETS‐VWF73, a first fluorogenic substrate for ADAMTS13 assay

  2005cited by this paper
• Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy

  2005cited by this paper
• VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.

  2004cited by this paper
• ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

  2003cited by this paper
• Assay of von Willebrand Factor (vWF)-cleaving Protease Based on Decreased Collagen Binding Affinity of Degraded vWF

  1999cited by this paper
• Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

  1998cited by this paper
• von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  1998cited by this paper
• Comparison of Plasma Exchange With Plasma Infusion in the Treatment of Thrombotic Thrombocytopenia Purpura

  1992cited by this paper
• Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

  1991cited by this paper
• Assessing predictive accuracy: how to compare Brier scores.

  1991cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY

  1950cited by this paper

• Pregnancy-Associated Thrombotic Thrombocytopenic Purpura: Diagnostic Pitfalls, Therapeutic Strategies, and Emerging Paradigms.

  2026cites this paper
• Hypertensive Havoc: When Malignant Hypertension Mimics Thrombotic Thrombocytopenic Purpura

  2026cites this paper
• Diagnostic and therapeutic challenges into snakebite-induced thrombotic microangiopathy: a case report and review of the literature

  2026cites this paper
• [34/f with thrombocytopenia and acute renal failure : Preparation for the medical specialist examination: part 19].

  2026cites this paper
• From dog bite to dialysis: complement-mediated haemolytic uraemic syndrome

  2026cites this paper
• Diagnosis and treatment of complement-mediated thrombotic microangiopathies: consensus of the Genetic Diseases Committee of the Chilean Society of Nephrology

  2026cites this paper
• 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura.

  2025cites this paper
• Vitamin B12 Deficiency-Induced Massive Schistocytosis and Hemolytic Anemia Due to Pseudo-Thrombotic Microangiopathy: A Case Report

  2025cites this paper
• A predictive algorithm involving lactate dehydrogenase to serum creatinine ratio may assist in identifying patients with thrombotic thrombocytopenic purpura

  2025influential citation
• Immune thrombotic thrombocytopenic purpura and diabetic ketoacidosis: a case report and literature review

  2025cites this paper
• Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis

  2025cites this paper
• A Woman With Headache, Fatigue, and Aphasia.

  2025cites this paper
• Do we still need plasma exchange to treat TMA? Yes.

  2025cites this paper
• The Hideous Side of Acute Pancreatitis: A Case of Pancreatitis-Induced Atypical Hemolytic Uremic Syndrome

  2025cites this paper
• Thrombotic Thrombocytopenic Purpura in Pediatric Patients

  2025cites this paper
• Diagnostic Value of Biological Parameters in Biopsy-Confirmed Thrombotic Microangiopathy–MATRIX Consortium Group

  2025cites this paper
• Real-world evaluation of a novel automated method for measuring ADAMTS13 activity using the Ceveron® s100 analyzer.

  2025cites this paper
• Determinants and clinical impact of time to plasma exchange in patients with immune thrombotic thrombocytopenic purpura

  2025cites this paper
• Thrombotic Microangiopathies.

  2025cites this paper
• Linking preclinical models to clinical realities: VEGF/VEGFR inhibitors and thrombotic microangiopathy in cancer therapy

  2025cites this paper
• Microangiopathic Anemia

  2025influential citation
• Hematologic Complications of Pregnancy

  2025cites this paper
• Immune Thrombotic Thrombocytopenic Purpura: A Review.

  2025cites this paper
• Systemic Lupus Erythematosus-Associated Thrombotic Thrombocytopenic Purpura: A Case Report

  2025cites this paper
• Improving the PLASMIC score with the use of RDW-SD in the differential diagnosis for thrombotic thrombocytopenic purpura in Chinese patients.

  2025cites this paper
• In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange?

  2025cites this paper
• Association of Therapeutic Plasma Exchange-Treated Thrombotic Thrombocytopenic Purpura with Improved Mortality Outcome in End-Stage Renal Disease

  2025cites this paper
• The Differential Diagnosis of Thrombocytopenia.

  2025cites this paper
• Fulminant myocarditis in immune‐mediated thrombotic thrombocytopenic purpura: A case report

  2025cites this paper
• Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomes

  2025cites this paper
• Efficacy and Safety of Rituximab in Connective Tissue Disease‐Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy

  2025cites this paper
• Microangiopathic haemolytic anaemia in colorectal cancer (CRC-MAHA): potential for salvage or terminal event?

  2025cites this paper
• Brain volumetric reductions in patients with thrombotic thrombocytopenic purpura

  2025cites this paper
• Post-miscarriage Complement-Mediated Thrombotic Microangiopathy in a 27-Year-Old Woman: A Case Highlighting Diagnostic and Therapeutic Gaps in Brazil

  2025cites this paper
• Thrombotic Thrombocytopenic Purpura and Evans Syndrome: Validating and Exploring 20 Years of Routine Hospital Care

  2025cites this paper
• Pancreatic Cancer Presenting with Thrombotic Thrombocytopenic Purpura: A Case Report and Review of Literature

  2025cites this paper
• Delayed Recovery of a Disintegrin-Like and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) Activity in Immune Thrombotic Thrombocytopenic Purpura Treated With Caplacizumab and Rituximab

  2025cites this paper
• Early administration of caplacizumab combined with plasma exchange for thrombotic microangiopathy due to malignant hypertension: a case report

  2025cites this paper
• PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database

  2025influential citation
• Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysis

  2025cites this paper
• Vitamin C Deficiency Megaloblastic Anemia Mimicking Hemolytic Anemia

  2025cites this paper
• Systematic Review of the Outcomes and Prognostic Factors of Patients With Systemic Lupus Erythematosus-Associated Thrombotic Microangiopathy

  2025cites this paper
• Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review

  2025cites this paper
• A case of thrombotic thrombocytopenic purpura induced by acute hepatitis E and successfully controlled by lymphoplasmapheresis plus rituximab

  2025cites this paper
• Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis at Cho Ray hospital, Vietnam

  2025cites this paper
• Atypisches hämolytisch-urämisches Syndrom: Differentialdiagnostik und Therapie

  2025cites this paper
• A case of STEC-negative hemolytic uremic syndrome with C2 gene mutation variant

  2025cites this paper
• The features and risk factors of thrombotic thrombocytopenic purpura in systemic lupus erythematosus

  2025cites this paper
• Thrombopenie und hämolytische Anämie in der Akut- und Notfallmedizin

  2025cites this paper
• The TMA team and TTP pathway improved outcomes in a cohort with Thrombotic thrombocytopenic purpura

  2025cites this paper
• Sjögren’s disease with mixed cryoglobulinemia presenting as a hypertensive emergency with thrombotic microangiopathy: a diagnostic puzzle

  2025cites this paper
• Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches

  2025cites this paper
• Microangiopathic Hemolytic Anemia as a Paraneoplastic Syndrome in a Patient with Metastatic Gastric Cancer

  2024cites this paper
• The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes

  2024cites this paper
• Immune‐mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report

  2024cites this paper
• Refractory Thrombotic Thrombocytopenic Purpura in a Patient With Triple X Syndrome

  2024cites this paper
• Practical approach to thrombocytopenia in patients with sepsis: a narrative review

  2024cites this paper
• Clinical and economic burden of suspected thrombotic thrombocytopenic purpura in US hospitals

  2024cites this paper
• Genetic variants contribute to modulation of renal function in patients with immune thrombotic thrombocytopenic purpura

  2024cites this paper
• ADAMTS13 in the New Era of TTP

  2024influential citation
• Nierenbeteiligung bei thrombotischer Mikroangiopathie

  2024cites this paper
• Immune Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, Therapy and Open Issues

  2024cites this paper
• Risk factors of death or chronic renal replacement therapy requirements in patients with thrombotic microangiopathies without ADAMTS‐13 deficiency

  2024cites this paper
• Vitamin B12 Deficiency Mimicking Thrombotic Thrombocytopenic Purpura: A Case Report and Review of Literature

  2024cites this paper
• The Historical Origins of Modern INR Targets.

  2024cites this paper
• Outcomes of patients with thrombotic thrombocytopenic purpura treated in an intensive care unit.

  2024cites this paper
• Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab—A case report

  2024cites this paper
• Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies

  2024cites this paper
• Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?

  2024cites this paper
• Diagnostic Challenges in a Case of Immune-Mediated Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency

  2024cites this paper
• Adult Vitamin B12 Deficiency-Associated Pseudo-Thrombotic Microangiopathy: A Systematic Review of Case Reports

  2024cites this paper
• Hypertensive Emergency with Thrombotic Microangiopathy or TTP? A Case Series and Literature Review

  2024cites this paper
• Hematological Complications of Human Immunodeficiency Virus (HIV) Infection: An Update From an HIV-Endemic Setting

  2024cites this paper
• A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura

  2024cites this paper
• Cancer‐related thrombotic microangiopathy and disseminated intravascular coagulation in a patient with bone marrow carcinomatosis of unknown primary origin: A case report

  2024cites this paper
• A Case-Based Narrative Review of Pregnancy-Associated Atypical Hemolytic Uremic Syndrome/Complement-Mediated Thrombotic Microangiopathy.

  2024cites this paper
• Le PTT, une microangiopathie thrombotique de l’hémostase

  2024cites this paper
• Thrombotic Microangiopathy in children: Redefining HUS, TTP and related disorders!

  2024cites this paper
• KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.

  2024cites this paper
• HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies

  2024cites this paper
• De-novo immune-mediated thrombotic thrombocytopenic purpura following surgical and non-surgical procedures: A systematic review.

  2024cites this paper
• Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons

  2024cites this paper
• Clinical features and prognostic factors of systemic lupus erythematosus related thrombotic microangiopathy: A retrospective study based on Chinese SLE Treatment and Research Group (CSTAR) registry.

  2024cites this paper
• Hickam’s Dictum: A Case of Intracerebral Hemorrhage with Multiple Contributing Risk Factors

  2024influential citation
• Exploration de l’hémostase primaire

  2024cites this paper
• Pregnancy-Induced Thrombotic Microangiopathy in Systematic Lupus Erythematosus: A Case Report

  2024cites this paper
• Primary Thrombotic Microangiopathy in Pediatric Patients

  2024influential citation
• Effect of peripheral blood absolute monocyte count at admission on relapse-free survival in patients with idiopathic thrombotic thrombocytopenic purpura in remission

  2024cites this paper
• Thrombotische Mikroangiopathie

  2024cites this paper
• Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura

  2024cites this paper
• Real‐World Retrospective Audit on the Use of the TechnoClone TECHNOSCREEN ADAMTS‐13 Assay in the Diagnostic Process for Thrombotic Thrombocytopenic Purpura at LabPlus, New Zealand

  2024cites this paper
• 51-Year-Old Woman With Bloody Diarrhea.

  2024cites this paper
• A Rare But Fatal Toxicity: Immune Checkpoint Inhibitor–Related Acquired Thrombotic Thrombocytopenic Purpura

  2024cites this paper
• Distinguishing thrombotic thrombocytopenic purpura from primary immune thrombocytopenia accompanied by anemia using the carbon monoxide breath test

  2024cites this paper
• Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency

  2024cites this paper
• [Management of congenital thrombotic thrombocytopenic purpura in the era of recombinant ADAMTS13 protein: Recommendations from the Reference Center for Thrombotic Microangiopathies (CNR-MAT)].

  2024cites this paper
• Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation.

  2024cites this paper
• Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

  2024cites this paper
• Assessing treatment response in thrombotic thrombocytopenic purpura: Beyond the platelet count

  2024cites this paper
• 100 Jahre Thrombotisch-thrombozytopenische Purpura (TTP) – Was haben wir gelernt?

  2024cites this paper